Prelude Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,000
Closed -$1.33M 1177
2025
Q1
$1.33M Buy
+8,000
New +$1.25M 0.1% 240
2021
Q2
Sell
-5,100
Closed -$838K 1811
2021
Q1
$838K Buy
5,100
+3,500
+219% +$566K 0.02% 664
2020
Q4
$252K Buy
+1,600
New +$236K 0.01% 998
2020
Q3
Sell
-18,800
Closed -$2.64M 2095
2020
Q2
$2.64M Buy
18,800
+18,400
+4,600% +$2.68M 0.15% 116
2020
Q1
$52K Sell
400
-18,500
-98% -$2.62M ﹤0.01% 749
2019
Q4
$2.76M Buy
+18,900
New +$2.56M 0.1% 137
2019
Q2
Sell
-22,500
Closed -$3.15M 1899
2019
Q1
$3.15M Buy
+22,500
New +$3.01M 0.18% 103

Other funds holding JNJ

Prelude Capital Management's JNJ Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 1,370 shares worth $348K. The stake represents 0.03% of the portfolio and ranks #689 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in JNJ as recently as Q4 2025.

Prelude Capital Management first reported a position in JNJ in Q2 2013 and has held it in 34 quarters since. The position peaked at $3.58M in Q3 2024. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Prelude Capital Management held 1,370 shares of Johnson & Johnson worth $348K as of Q2 2026.
  • Johnson & Johnson was a new Prelude Capital Management position in Q2 2026.
  • Johnson & Johnson made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #689 holding.
  • Prelude Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 34 quarters since.
  • Prelude Capital Management's Johnson & Johnson position peaked at $3.58M in Q3 2024.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.